It was reported yesterday that Mylan, a global generic and specialty pharmaceuticals company, has launched Ibandronate Sodium Injection, one mg (base)/mL, packaged in three mg (base)/three mL pre-filled glass syringes.
According to IMS Health, Ibandronate Sodium Injection, one mg (base)/mL, packaged in three mg (base)/ three mL pre-filled glass syringes had US sales of about USD18.
Reddy's Ibandronate sodium
tablets in 150 mg are available in cartons of 3 blister packs containing 1 tablet each (once monthly dosing).
Reddya[euro](tm)s Laboratories unveils US FDA approved Ibandronate Sodium
tablets 150mg(C)2012 M2 COMMUNICATIONS http://www.
for osteoporosis in postmenopausal women (Protocol).
In Japan, a Phase III study was conducted in approximately 400 patients with osteoporosis to assess efficacy and safety of RG484/CT-064 oral agent against ibandronate sodium
is approved by the FDA for the treatment (2.
announced today that ibandronate sodium
hydrate (generic name) oral agent demonstrated non-inferiority in efficacy of increasing the bone mass of the lumbar spine compared to a comparator, ibandronate sodium
announced today that they launched the ibandronate sodium
hydrate, a bisphosphonate antiresorptive agent brand name: Bonviva Injection 1 mg Syringe (hereafter, Bonviva IV Injection ) , for the indication of osteoporosis on August 29, 2013.